ID   CP27B_HUMAN             Reviewed;         508 AA.
AC   O15528; B2RC61; Q548T3;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   10-MAY-2017, entry version 165.
DE   RecName: Full=25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial;
DE            EC=1.14.15.18 {ECO:0000269|PubMed:10518789};
DE   AltName: Full=25-OHD-1 alpha-hydroxylase;
DE   AltName: Full=25-hydroxyvitamin D(3) 1-alpha-hydroxylase;
DE            Short=VD3 1A hydroxylase;
DE   AltName: Full=Calcidiol 1-monooxygenase;
DE   AltName: Full=Cytochrome P450 subfamily XXVIIB polypeptide 1;
DE   AltName: Full=Cytochrome P450C1 alpha;
DE   AltName: Full=Cytochrome P450VD1-alpha;
DE   AltName: Full=Cytochrome p450 27B1;
DE   Flags: Precursor;
GN   Name=CYP27B1; Synonyms=CYP1ALPHA, CYP27B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9428799; DOI=10.1089/dna.1997.16.1499;
RA   Fu G.K., Portale A.P., Miller W.L.;
RT   "Complete structure of the human gene for the vitamin D 1alpha-
RT   hydroxylase, P450c1alpha.";
RL   DNA Cell Biol. 16:1499-1507(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Kidney;
RX   PubMed=9344864; DOI=10.1006/bbrc.1997.7508;
RA   Monkawa T., Yoshida T., Wakino S., Shinki T., Anazawa H., Deluca H.F.,
RA   Suda T., Hayashi M., Saruta T.;
RT   "Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin
RT   D3 1 alpha-hydroxylase.";
RL   Biochem. Biophys. Res. Commun. 239:527-533(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9415400; DOI=10.1210/mend.11.13.0035;
RA   Fu G.K., Lin D., Zhang Y.H., Bikle D.D., Shackleton C.H., Miller W.L.,
RA   Portale A.A.;
RT   "Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and
RT   mutations causing vitamin D-dependent rickets type 1.";
RL   Mol. Endocrinol. 11:1961-1970(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12496369;
RA   Huang D.C., Papavasiliou V., Rhim J.S., Horst R.L., Kremer R.;
RT   "Targeted disruption of the 25-hydroxyvitamin D3 1alpha-hydroxylase
RT   gene in ras-transformed keratinocytes demonstrates that locally
RT   produced 1alpha,25-dihydroxyvitamin D3 suppresses growth and induces
RT   differentiation in an autocrine fashion.";
RL   Mol. Cancer Res. 1:56-67(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Huang D.C., Papavasiliou J., Rhim J., Kremer R.;
RT   "Targeted disruption of the 25-hydroxyvitamin D3 1 a-hydroxylase gene
RT   in a Ras-transformed human keratinocyte cell line: evidence for an
RT   autocrine growth regulatory function of 1 alpha, 25-dihydroxyvitamin
RT   D3 in vitro and in vivo.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LEU-166.
RG   NIEHS SNPs program;
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10518789; DOI=10.1046/j.1432-1327.1999.00794.x;
RA   Sawada N., Sakaki T., Kitanaka S., Takeyama K., Kato S., Inouye K.;
RT   "Enzymatic properties of human 25-hydroxyvitamin D3 1alpha-hydroxylase
RT   coexpression with adrenodoxin and NADPH-adrenodoxin reductase in
RT   Escherichia coli.";
RL   Eur. J. Biochem. 265:950-956(1999).
RN   [11]
RP   VARIANTS VDDR1A HIS-107; GLU-125; PRO-335 AND SER-382.
RX   PubMed=9486994; DOI=10.1056/NEJM199803053381004;
RA   Kitanaka S., Takeyama K., Murayama A., Sato T., Okumura K., Nogami M.,
RA   Hasegawa Y., Niimi H., Yanagisawa J., Tanaka T., Kato S.;
RT   "Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase
RT   gene in patients with pseudovitamin D-deficiency rickets.";
RL   N. Engl. J. Med. 338:653-661(1998).
RN   [12]
RP   VARIANTS VDDR1A HIS-65; LYS-189; HIS-389; ILE-409; PRO-429; CYS-453
RP   AND ARG-497.
RX   PubMed=9837822; DOI=10.1086/302156;
RA   Wang J.T., Lin C.-J., Burridge S.M., Fu G.K., Labuda M., Portale A.A.,
RA   Miller W.L.;
RT   "Genetics of vitamin D 1-alpha-hydroxylase deficiency in 17
RT   families.";
RL   Am. J. Hum. Genet. 63:1694-1702(1998).
RN   [13]
RP   VARIANTS VDDR1A TYR-323 AND GLY-478.
RX   PubMed=10320521; DOI=10.1359/jbmr.1999.14.5.730;
RA   Smith S.J., Rucka A.K., Berry J.L., Davies M., Mylchreest S.,
RA   Paterson C.R., Heath D.A., Tassabehji M., Read A.P., Mee A.P.,
RA   Mawer E.B.;
RT   "Novel mutations in the 1alpha-hydroxylase (P450c1) gene in three
RT   families with pseudovitamin D-deficiency rickets resulting in loss of
RT   functional enzyme activity in blood-derived macrophages.";
RL   J. Bone Miner. Res. 14:730-739(1999).
RN   [14]
RP   VARIANTS VDDR1A ARG-321 AND CYS-389.
RX   PubMed=10566658; DOI=10.1210/jcem.84.11.6131;
RA   Kitanaka S., Murayama A., Sakaki T., Inouye K., Seino Y., Fukumoto S.,
RA   Shima M., Yukizane S., Takayanagi M., Niimi H., Takeyama K., Kato S.;
RT   "No enzyme activity of 25-hydroxyvitamin D3 1alpha-hydroxylase gene
RT   product in pseudovitamin D deficiency rickets, including that with
RT   mild clinical manifestation.";
RL   J. Clin. Endocrinol. Metab. 84:4111-4117(1999).
RN   [15]
RP   VARIANTS VDDR1A GLY-189; PHE-343; GLY-389; HIS-389 AND ILE-409.
RX   PubMed=12050193; DOI=10.1210/jcem.87.6.8534;
RA   Wang X., Zhang M.Y., Miller W.L., Portale A.A.;
RT   "Novel gene mutations in patients with 1alpha-hydroxylase deficiency
RT   that confer partial enzyme activity in vitro.";
RL   J. Clin. Endocrinol. Metab. 87:2424-2430(2002).
CC   -!- FUNCTION: Catalyzes the conversion of 25-hydroxyvitamin D3
CC       (25(OH)D3) to 1-alpha,25-dihydroxyvitamin D3 (1alpha,25(OH)(2)D3),
CC       and of 24,25-dihydroxyvitamin D3 (24,25(OH)(2)D3) to 1-
CC       alpha,24,25-trihydroxyvitamin D3 (1alpha,24,25(OH)(3)D3). Is also
CC       active with 25-hydroxy-24-oxo-vitamin D3. Plays an important role
CC       in normal bone growth, calcium metabolism, and tissue
CC       differentiation. {ECO:0000269|PubMed:10518789}.
CC   -!- CATALYTIC ACTIVITY: Calcidiol + 2 reduced adrenodoxin + 2 H(+) +
CC       O(2) = calcitriol + 2 oxidized adrenodoxin + H(2)O.
CC       {ECO:0000269|PubMed:10518789}.
CC   -!- CATALYTIC ACTIVITY: Secalciferol + 2 reduced adrenodoxin + 2 H(+)
CC       + O(2) = calcitetrol + 2 oxidized adrenodoxin + H(2)O.
CC       {ECO:0000269|PubMed:10518789}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.7 uM for 25-hydroxyvitamin D3
CC         {ECO:0000269|PubMed:10518789};
CC         KM=1.1 uM for 24,25-dihydroxyvitamin D3
CC         {ECO:0000269|PubMed:10518789};
CC         Vmax=3.9 pmol/min/mg enzyme with 25-hydroxyvitamin D3 as
CC         substrate {ECO:0000269|PubMed:10518789};
CC         Vmax=3.2 pmol/min/mg enzyme with 24,25-dihydroxyvitamin D3 as
CC         substrate {ECO:0000269|PubMed:10518789};
CC   -!- PATHWAY: Hormone biosynthesis; cholecalciferol biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion membrane.
CC   -!- TISSUE SPECIFICITY: Kidney.
CC   -!- DISEASE: Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]: A
CC       disorder caused by a selective deficiency of the active form of
CC       vitamin D (1,25-dihydroxyvitamin D3) and resulting in defective
CC       bone mineralization and clinical features of rickets.
CC       {ECO:0000269|PubMed:10320521, ECO:0000269|PubMed:10566658,
CC       ECO:0000269|PubMed:12050193, ECO:0000269|PubMed:9486994,
CC       ECO:0000269|PubMed:9837822}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cyp27b1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF027152; AAC51854.1; -; Genomic_DNA.
DR   EMBL; AB005038; BAA23416.1; -; mRNA.
DR   EMBL; AB005989; BAA22656.1; -; mRNA.
DR   EMBL; AB005990; BAA22657.1; -; Genomic_DNA.
DR   EMBL; AB006987; BAA23418.1; -; Genomic_DNA.
DR   EMBL; AF020192; AAC51853.1; -; mRNA.
DR   EMBL; AF256213; AAG00416.1; -; Genomic_DNA.
DR   EMBL; AF246895; AAF64299.1; -; mRNA.
DR   EMBL; AY288916; AAP31972.1; -; Genomic_DNA.
DR   EMBL; AK314953; BAG37458.1; -; mRNA.
DR   EMBL; CH471054; EAW97067.1; -; Genomic_DNA.
DR   EMBL; BC136386; AAI36387.1; -; mRNA.
DR   CCDS; CCDS8954.1; -.
DR   PIR; JC5713; JC5713.
DR   RefSeq; NP_000776.1; NM_000785.3.
DR   UniGene; Hs.524528; -.
DR   ProteinModelPortal; O15528; -.
DR   SMR; O15528; -.
DR   STRING; 9606.ENSP00000228606; -.
DR   BindingDB; O15528; -.
DR   ChEMBL; CHEMBL5993; -.
DR   DrugBank; DB01436; Alfacalcidol.
DR   DrugBank; DB00146; Calcidiol.
DR   DrugBank; DB01285; Corticotropin.
DR   DrugBank; DB00153; Ergocalciferol.
DR   GuidetoPHARMACOLOGY; 1370; -.
DR   SwissLipids; SLP:000001478; -.
DR   PhosphoSitePlus; O15528; -.
DR   BioMuta; CYP27B1; -.
DR   PaxDb; O15528; -.
DR   PeptideAtlas; O15528; -.
DR   PRIDE; O15528; -.
DR   TopDownProteomics; O15528; -.
DR   Ensembl; ENST00000228606; ENSP00000228606; ENSG00000111012.
DR   GeneID; 1594; -.
DR   KEGG; hsa:1594; -.
DR   UCSC; uc001spz.2; human.
DR   CTD; 1594; -.
DR   DisGeNET; 1594; -.
DR   GeneCards; CYP27B1; -.
DR   H-InvDB; HIX0171662; -.
DR   HGNC; HGNC:2606; CYP27B1.
DR   MalaCards; CYP27B1; -.
DR   MIM; 264700; phenotype.
DR   MIM; 609506; gene.
DR   neXtProt; NX_O15528; -.
DR   OpenTargets; ENSG00000111012; -.
DR   Orphanet; 289157; Hypocalcemic vitamin D-dependent rickets.
DR   PharmGKB; PA27099; -.
DR   eggNOG; KOG0159; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000119243; -.
DR   HOGENOM; HOG000253961; -.
DR   HOVERGEN; HBG106909; -.
DR   InParanoid; O15528; -.
DR   KO; K07438; -.
DR   OMA; HRQRACG; -.
DR   OrthoDB; EOG091G0MI3; -.
DR   PhylomeDB; O15528; -.
DR   TreeFam; TF105094; -.
DR   BRENDA; 1.14.13.13; 2681.
DR   Reactome; R-HSA-196791; Vitamin D (calciferol) metabolism.
DR   Reactome; R-HSA-211916; Vitamins.
DR   UniPathway; UPA00955; -.
DR   GeneWiki; 25-Hydroxyvitamin_D3_1-alpha-hydroxylase; -.
DR   GenomeRNAi; 1594; -.
DR   PRO; PR:O15528; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111012; -.
DR   CleanEx; HS_CYP27B1; -.
DR   ExpressionAtlas; O15528; baseline and differential.
DR   Genevisible; O15528; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005741; C:mitochondrial outer membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; ISS:BHF-UCL.
DR   GO; GO:0004498; F:calcidiol 1-monooxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0030282; P:bone mineralization; IEP:BHF-UCL.
DR   GO; GO:0036378; P:calcitriol biosynthetic process from calciol; IDA:BHF-UCL.
DR   GO; GO:0055074; P:calcium ion homeostasis; IMP:BHF-UCL.
DR   GO; GO:0006816; P:calcium ion transport; ISS:BHF-UCL.
DR   GO; GO:0046697; P:decidualization; IEP:BHF-UCL.
DR   GO; GO:0070314; P:G1 to G0 transition; IMP:BHF-UCL.
DR   GO; GO:0010956; P:negative regulation of calcidiol 1-monooxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; IMP:BHF-UCL.
DR   GO; GO:0010980; P:positive regulation of vitamin D 24-hydroxylase activity; IDA:BHF-UCL.
DR   GO; GO:0070564; P:positive regulation of vitamin D receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0030500; P:regulation of bone mineralization; IMP:BHF-UCL.
DR   GO; GO:0043627; P:response to estrogen; IEP:BHF-UCL.
DR   GO; GO:0034341; P:response to interferon-gamma; IDA:BHF-UCL.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IDA:BHF-UCL.
DR   GO; GO:0033280; P:response to vitamin D; IDA:BHF-UCL.
DR   GO; GO:0042369; P:vitamin D catabolic process; IEA:Ensembl.
DR   GO; GO:0042359; P:vitamin D metabolic process; IDA:BHF-UCL.
DR   GO; GO:0006766; P:vitamin metabolic process; TAS:Reactome.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; Heme; Iron; Membrane;
KW   Metal-binding; Mitochondrion; Monooxygenase; NADP; Oxidoreductase;
KW   Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1      ?       Mitochondrion. {ECO:0000255}.
FT   CHAIN         ?    508       25-hydroxyvitamin D-1 alpha hydroxylase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000003622.
FT   METAL       455    455       Iron (heme axial ligand). {ECO:0000250}.
FT   VARIANT      65     65       Q -> H (in VDDR1A; dbSNP:rs868704228).
FT                                {ECO:0000269|PubMed:9837822}.
FT                                /FTId=VAR_016969.
FT   VARIANT     107    107       R -> H (in VDDR1A; complete loss of
FT                                activity; dbSNP:rs28934604).
FT                                {ECO:0000269|PubMed:9486994}.
FT                                /FTId=VAR_016952.
FT   VARIANT     125    125       G -> E (in VDDR1A; complete loss of
FT                                activity; dbSNP:rs28934605).
FT                                {ECO:0000269|PubMed:9486994}.
FT                                /FTId=VAR_016953.
FT   VARIANT     166    166       V -> L (in dbSNP:rs8176344).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_018841.
FT   VARIANT     189    189       E -> G (in VDDR1A; 22% of wild-type
FT                                activity; dbSNP:rs118204012).
FT                                {ECO:0000269|PubMed:12050193}.
FT                                /FTId=VAR_016954.
FT   VARIANT     189    189       E -> K (in VDDR1A; 11% of wild-type
FT                                activity). {ECO:0000269|PubMed:9837822}.
FT                                /FTId=VAR_016967.
FT   VARIANT     321    321       T -> R (in VDDR1A; complete loss of
FT                                activity; dbSNP:rs118204007).
FT                                {ECO:0000269|PubMed:10566658}.
FT                                /FTId=VAR_016955.
FT   VARIANT     323    323       S -> Y (in VDDR1A).
FT                                {ECO:0000269|PubMed:10320521}.
FT                                /FTId=VAR_016970.
FT   VARIANT     335    335       R -> P (in VDDR1A; complete loss of
FT                                activity; dbSNP:rs28934606).
FT                                {ECO:0000269|PubMed:9486994}.
FT                                /FTId=VAR_016956.
FT   VARIANT     343    343       L -> F (in VDDR1A; 2.3% of wild-type
FT                                activity; dbSNP:rs118204011).
FT                                {ECO:0000269|PubMed:12050193}.
FT                                /FTId=VAR_016957.
FT   VARIANT     382    382       P -> S (in VDDR1A; complete loss of
FT                                activity; dbSNP:rs28934607).
FT                                {ECO:0000269|PubMed:9486994}.
FT                                /FTId=VAR_016958.
FT   VARIANT     389    389       R -> C (in VDDR1A; complete loss of
FT                                activity; dbSNP:rs118204010).
FT                                {ECO:0000269|PubMed:10566658}.
FT                                /FTId=VAR_016968.
FT   VARIANT     389    389       R -> G (in VDDR1A; complete loss of
FT                                activity; dbSNP:rs118204010).
FT                                {ECO:0000269|PubMed:12050193}.
FT                                /FTId=VAR_016960.
FT   VARIANT     389    389       R -> H (in VDDR1A; complete loss of
FT                                activity; dbSNP:rs118204009).
FT                                {ECO:0000269|PubMed:12050193,
FT                                ECO:0000269|PubMed:9837822}.
FT                                /FTId=VAR_016959.
FT   VARIANT     409    409       T -> I (in VDDR1A; dbSNP:rs118204008).
FT                                {ECO:0000269|PubMed:12050193,
FT                                ECO:0000269|PubMed:9837822}.
FT                                /FTId=VAR_016961.
FT   VARIANT     429    429       R -> P (in VDDR1A).
FT                                {ECO:0000269|PubMed:9837822}.
FT                                /FTId=VAR_016971.
FT   VARIANT     453    453       R -> C (in VDDR1A; dbSNP:rs767480544).
FT                                {ECO:0000269|PubMed:9837822}.
FT                                /FTId=VAR_016972.
FT   VARIANT     478    478       V -> G (in VDDR1A).
FT                                {ECO:0000269|PubMed:10320521}.
FT                                /FTId=VAR_016973.
FT   VARIANT     497    497       P -> R (in VDDR1A).
FT                                {ECO:0000269|PubMed:9837822}.
FT                                /FTId=VAR_016974.
FT   CONFLICT    320    320       D -> N (in Ref. 7; BAG37458).
FT                                {ECO:0000305}.
SQ   SEQUENCE   508 AA;  56504 MW;  7F0611EFAD1B5C1C CRC64;
     MTQTLKYASR VFHRVRWAPE LGASLGYREY HSARRSLADI PGPSTPSFLA ELFCKGGLSR
     LHELQVQGAA HFGPVWLASF GTVRTVYVAA PALVEELLRQ EGPRPERCSF SPWTEHRRCR
     QRACGLLTAE GEEWQRLRSL LAPLLLRPQA AARYAGTLNN VVCDLVRRLR RQRGRGTGPP
     ALVRDVAGEF YKFGLEGIAA VLLGSRLGCL EAQVPPDTET FIRAVGSVFV STLLTMAMPH
     WLRHLVPGPW GRLCRDWDQM FAFAQRHVER REAEAAMRNG GQPEKDLESG AHLTHFLFRE
     ELPAQSILGN VTELLLAGVD TVSNTLSWAL YELSRHPEVQ TALHSEITAA LSPGSSAYPS
     ATVLSQLPLL KAVVKEVLRL YPVVPGNSRV PDKDIHVGDY IIPKNTLVTL CHYATSRDPA
     QFPEPNSFRP ARWLGEGPTP HPFASLPFGF GKRSCMGRRL AELELQMALA QILTHFEVQP
     EPGAAPVRPK TRTVLVPERS INLQFLDR
//
